{"product_id":"acg-gi-pathophysiology-course-2021","title":"ACG GI Pathophysiology Course 2021","description":"\u003cdiv class=\"titleBar\"\u003e\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_SideBySideDetails_pnlLearningActivitySubtitle\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper container tabbed-content\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"so-panel widget widget_text\" data-index=\"3\" id=\"panel-817-1-0-1\"\u003e\n\u003ctable class=\"table table-schedule\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth class=\"h3 text-uppercase\"\u003e\n\u003cb\u003e\u003cb\u003eFRIDAY, OCTOBER 22, 2021 │ ALL TIMES ARE LISTED IN THE PACIFIC TIME ZONE\u003c\/b\u003e\u003c\/b\u003e\n\u003cbr\u003e\u003ch1 class=\"product-title product_title entry-title\"\u003eACG GI Pathophysiology Course 2021\u003c\/h1\u003e\n\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:35 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eProton Pump Inhibitor Adverse Effects: Fact or Fiction?\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePaul Moayyedi, MB ChB, PhD, MPH, FACG\u003c\/em\u003e\u003cbr\u003eDescribe the scientific rationale and evidence for adverse effects of proton pump inhibitor therapy.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:05 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eScientific Foundations of Novel Immunologic Approaches to IBD\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eMiguel D. Regueiro, MD, FACG\u003c\/em\u003e\u003cbr\u003eApply concepts regarding the immunologic basis of novel biologic therapies to the management of IBD.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:35 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRationale for Targeting Eosinophils in Achalasia, Eosinophilic Gastrointestinal Disease,\u003cbr\u003eand Functional Gastrointestinal Disorders\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eNirmala P. Gonsalves, MD\u003c\/em\u003e\u003cbr\u003eAppreciate the rationale for growing interest in novel therapies targeting eosinophils in the management of achalasia, eosinophilic gastrointestinal disease, and functional GI disorders.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:05 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eQ \u0026amp; A\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:35 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:55 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePathophysiology Basis for Current and Future Management of Acute Pancreatitis\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eGeorge I. Papachristou, MD, PhD, FACG\u003c\/em\u003e\u003cbr\u003eIdentify the scientific basis for novel therapeutic approaches to pancreatitis.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:25 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eApplication of Molecular and Genetic Testing to the Management of Colon Polyps and Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eElena M. Stoffel, MD, MPH\u003c\/em\u003e\u003cbr\u003eFormulate a clinical approach to the use of molecular and genetic testing in the evaluation and management of colon polyps and cancer.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:55 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eMechanistic Underpinnings for the Management of Refractory Constipation\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eDarren M. Brenner, MD, FACG\u003c\/em\u003e\u003cbr\u003eApply concepts regarding the physiologic basis of constipation to inform therapeutic decisions for patients with refractory constipation.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:25 am\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCeliac Disease: From Disease Understanding to Management Strategies\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eAmy S. Oxentenko, MD, FACG\u003c\/em\u003e\u003cbr\u003eDetail the mechanisms of celiac disease as well as diagnostic and management strategies for patients.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:55 am\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eQ \u0026amp; A and Course Wrap-Up\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:30 pm\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCourse Adjourns\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954402889826,"sku":"MED-AMB02787","price":35.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ACG-GI-Pathophysiology-Course-2021.jpg?v=1779375541","url":"https:\/\/meducourse.com\/products\/acg-gi-pathophysiology-course-2021","provider":"Meducourse","version":"1.0","type":"link"}